Clinical Study of Apatinib Combined With Temozolomide in the Treatment of Uncontrolled or Repeated High-grade Gliomas
Status:
Recruiting
Trial end date:
2022-12-30
Target enrollment:
Participant gender:
Summary
Gliomas are the most common malignant tumors of the central nervous system and are highly
invasive. Gliomas account for one-third of central nervous system tumors in adults and
children. Interstitial astrocytomas and glioblastomas are also called high-grade gliomas,
accounting for 77.5% of all gliomas.